Skip to content

XOMA Corporation XOMA Interest Paid

Interest Paid at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$97K0.0%
Royalty Pharma logo
Royalty PharmaRPRX
$173.53M+25.0%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$2.77M-46.5%
ALN
Alnylam PharmaceuticalsALNY
$64.2M-6.9%
Xencor logo
XencorXNCR
$1K0.0%
Roivant Sciences logo
Roivant SciencesROIV
$0-100%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's interest paid?
XOMA Corporation (XOMA) reported interest paid of $5.56M in Q1 2026.
How has XOMA Corporation's interest paid changed year-over-year?
XOMA Corporation's interest paid decreased by 8.6% year-over-year, from $6.08M to $5.56M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.